Eradication of Helicobacter pylori Restores the Inhibitory Effect of Cholecystokinin on Gastric Motility in Duodenal Ulcer Patients

References

• Baron JH. The clinical use of gastric function tests. Scand J Gastroenterol 1970;6:9–17.
   Google Scholar
• Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995;37:482–7.
   PubMed Web of Science ®Google Scholar
• Konturek JW, Bielanski W, Konturek SJ, Domschke W. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. J Physiol Pharmacol 1996; 47:161–75.
   PubMed Web of Science ®Google Scholar
• Kosaka T, Lim RKS. Demonstration of the humoral agent in fat inhibited gastric secretion. Exp Biol Med 1930;27:880–91.
   Google Scholar
• Konturek SJ, Grossman MI. Effect of perfusion of intestinal loop with acid, fat and dextrose on gastric secretion. Gastroenterology 1965;49:481–9.
   PubMed Web of Science ®Google Scholar
• Debas HT, Farooq O, Grossman MI. Inhibition of gastric emptying is a physiological action of cholecystokinin. Gastroenterology 1975;68:1211–7.
   Google Scholar
• Liddle RA, Moriata ET, Conrad CT, Williams JA. Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 1986;77:992–6.
   PubMed Web of Science ®Google Scholar
• Konturek SJ, Kwiecien N, Obtulowicz W, Kopp B, Oleksy J, Rovati L. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. Digestion 1990;45:1–8.
   PubMed Web of Science ®Google Scholar
• Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RSL, Clineschmidt BV. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther 1986;241:103–9.
   Google Scholar
• Lam SK, Isenberg JI, Grossman MI, Lane WH, Hogan DL. Rapid gastric emptying in duodenal ulcer patients. Dig Dis Sci 1982;27:598–604.
   Google Scholar
• Maddern GJ, Horowitz M, Hetzel DJ, Jamiesson GG. Altered solid and liquid gastric emptying in patients with duodenal ulcer disease. Gut 1985;26:689–93.
   PubMed Web of Science ®Google Scholar
• Williams NS, Elashoff J, Meyer JH. Gastric emptying of liquids in normal subjects and patients with healed duodenal ulcer disease. Dig Dis Sci 1986;31:943–52.
   Google Scholar
• Parr NJ, Grime S, Critchley M, Baxter JN, Mackie CR. Abnormal pattern of gastric emptying of liquid in chronic duodenal ulcer. Digestion 1988;40:237–43.
   Google Scholar
• Hamlet A, Olbe L. The influence of Helicobacter pylori infection on postprandial duodenal acid load and duodenal bulb pH in humans. Gastroenterology 1996;111:391–400.
   PubMed Web of Science ®Google Scholar
• Konturek JW, Thor P, Domschke W. Effect of nitric oxide on antral motility and gastric emptying in humans. Eur J Gastroenterol Hepatol 1995;7:97–102.
   PubMed Web of Science ®Google Scholar
• Konturek JW, Fischer H, van der Voort IR, Domschke W. Disturbed gastric motor activity in patients with human immunodeficiency virus infection. Scand J Gastroenterol 1997; 32:221–5.
   PubMed Web of Science ®Google Scholar
• Konturek JW, Thor P, Maczka M, Stoll R, Domschke W, Konturek SJ. Role of cholecystokinin in the control of gastric emptying and gastric secretory response to a fatty meal in normal subjects and duodenal ulcer patients. Scand J Gastroenterol 1994;29:583–90.
   PubMed Web of Science ®Google Scholar
• Beglinger C, Hildebrand P, Meier R, et al. A physiological role of cholecystokinin as a regulator of gastrin secretion. Gastroenterology 1992;103:490–5.
   PubMed Web of Science ®Google Scholar
• Tucci A, Poli L, Tosetti C, Biasco G, Grigioni W, Varioli O, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998;93:1425–31.
   PubMed Web of Science ®Google Scholar
• Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accomodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999;44:55–64.
   PubMed Web of Science ®Google Scholar
• Chey WY, Hitanant S, Hendricks J. Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man. Gastroenterology 1979;58:820–7.
   Google Scholar
• Valenzuela JE, Defilippi C. Inhibition of gastric emptying in humans by secretin, the octapeptide of cholecystokinin and intraduodenal fat. Gastroenterology 1981;81:898–902.
   PubMed Web of Science ®Google Scholar
• Walsh JH. Gastrointestinal hormones. In: Johnson JR, editor. Physiology of the gastrointestinal tract. New York: Raven Press; 1994. p. 32–60.
   Google Scholar
• Lloyd KC, Maxwell V, Kovacs TOG, Walsh JH. Cholecystokinin receptor antagonist MK-329 blocks intestinal fat-induced inhibition of meal-stimulated gastric acid secretion. Gastroenterology 1992;102:131–8.
   PubMed Web of Science ®Google Scholar
• Konturek SJ, Bilski J, Tasler J, Cieszkowski M. Role of cholecystokinin in the inhibition of gastric secretion in dogs. J Physiol (Lond) 1992;451:477–89.
   Google Scholar
• Jin HO, Lee KY, Chang TM, Chey WY, Dubois A. Physiological role of cholecystokinin on gastric emptying and acid output in dogs. Dig Dis Sci 1994;39:2306–14.
   Google Scholar
• Soll AH, Amirian DA, Park J, Elashoff JD, Yamada T. Cholecystokinin potently releases somatostatin from canine fundic mucosal cells in primary culture. Am J Physiol 1984; 247:G556–8.
   Google Scholar
• Konturek JW, Stoll R, Gutwinska-Konturek M, Konturek SJ, Domschke W. Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans. Scand J Gastroenterol 1993;28:401–7.
   Google Scholar
• Chayvialle JAP, Descos F, Bernard C, Maninin A, Barbe C, Patensky C. Somatostatin in mucosa of stomach and duodenum in gastroduodenal disease. Gastroenterology 1978;75:13–9.
   PubMed Web of Science ®Google Scholar
• Harty RF, Malco DG, McGuigan JE. Antral release of gastrin and somatostatin in duodenal ulcer and control subjects. Gut 1986;27:652–8.
   Google Scholar
• McHenry I, Vuyyuruu L, Schubert ML. Helicobacter pylori and duodenal ulcer disease: the somatostatin link? Gastroenterology 1993;104: 1573–5.
   Google Scholar
• Kaneko H, Nakada K, Mitsuma T, Uchida K, Furusawa A, Maeda Y. H. pylori infection induces a decrease in immunoreactive somatostatin concentrations in human stomach. Dig Dis Sci 1992;37: 409–16.
   Google Scholar
• Jonderko G, Jonderko K, Golab T. Effect of somatostatin-14 on gastric emptying and on gastrin and insulin release after ingestion of a mixed solid-liquid meal in man. Mater Med Pol 1989;21: 174–80.
   Google Scholar
• Okamoto E, Haruma K, Hata J, Tani H, Sumii K, Kajiyama G. Effects of octreotide, a somatostatin analogue, on gastric function evaluated by real-time ultrasonography. Aliment Pharmacol Ther 1997;11:177–84.
   PubMed Web of Science ®Google Scholar